These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 7817919)
1. Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty. Godfried SL; Deckelbaum LI Am Heart J; 1995 Jan; 129(1):203-10. PubMed ID: 7817919 [No Abstract] [Full Text] [Related]
2. Angioscopic prediction of successful dilatation and of restenosis in percutaneous transluminal coronary angioplasty. Significance of yellow plaque. Itoh A; Miyazaki S; Nonogi H; Daikoku S; Haze K Circulation; 1995 Mar; 91(5):1389-96. PubMed ID: 7867178 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. French BA; Mazur W; Ali NM; Geske RS; Finnigan JP; Rodgers GP; Roberts R; Raizner AE Circulation; 1994 Nov; 90(5):2402-13. PubMed ID: 7955199 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic roles of heparin and glucocorticoids to prevent restenosis after coronary angioplasty. Berk BC; Gordon JB; Alexander RW J Am Coll Cardiol; 1991 May; 17(6 Suppl B):111B-117B. PubMed ID: 2016469 [TBL] [Abstract][Full Text] [Related]
5. Arterial remodelling after percutaneous transluminal balloon angioplasty. Rozenman Y; Lotan C; Gilon D; Mosseri M; Sapoznikov D; Welber S; Gotsman MS Adv Exp Med Biol; 1993; 346():277-82. PubMed ID: 8184765 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter). Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609 [TBL] [Abstract][Full Text] [Related]
7. Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty. Manegold C; Alwazzeh M; Jablonowski H; Adams O; Medve M; Seidlitz B; Heidland U; Häussinger D; Strauer BE; Heintzen MP Circulation; 1999 Mar; 99(10):1290-4. PubMed ID: 10077511 [TBL] [Abstract][Full Text] [Related]
8. Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty. Macdonald RG; Panush RS; Pepine CJ Am J Cardiol; 1987 Jul; 60(3):56B-60B. PubMed ID: 2956845 [TBL] [Abstract][Full Text] [Related]
9. Restenosis after coronary balloon angioplasty. Lange RA; Flores ED; Hillis LD Annu Rev Med; 1991; 42():127-32. PubMed ID: 2035958 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous coronary intervention in small coronary vessels: from balloon angioplasty to drug eluting stent era. Rathore S; Kaul U Indian Heart J; 2011; 63(3):228-33. PubMed ID: 22734340 [TBL] [Abstract][Full Text] [Related]
12. Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Roguin A; Hochberg I; Nikolsky E; Markiewicz W; Meisel SR; Hir J; Grenadier E; Beyar R; Levy AP Am J Cardiol; 2001 Feb; 87(3):330-2, A9. PubMed ID: 11165970 [TBL] [Abstract][Full Text] [Related]
13. Prevention of restenosis with antioxidants: mechanisms and implications. Tardif JC; Grégoire J; L'Allier PL Am J Cardiovasc Drugs; 2002; 2(5):323-34. PubMed ID: 14727962 [TBL] [Abstract][Full Text] [Related]
14. [Percutaneous transluminal coronary angioplasty (PTCA) in diabetic patients. Part 1: failure due to restenosis after simple PTCA]. Warzée F; Legrand V; Scheen AJ Rev Med Liege; 2004 Oct; 59(10):584-90. PubMed ID: 15623079 [TBL] [Abstract][Full Text] [Related]
15. Electron-beam computed tomographic detection of coronary calcification in patients undergoing percutaneous transluminal coronary angioplasty: predictability of restenosis. A preliminary report. Stanford W; Travis ME; Thompson BH; Reiners TJ; Hasson RR; Winniford MD Am J Card Imaging; 1995 Oct; 9(4):257-60. PubMed ID: 8680142 [TBL] [Abstract][Full Text] [Related]
16. Value of exercise electrocardiography in the detection of restenosis after coronary angioplasty in patients with one-vessel disease. Malekianpour M; Rodés J; Côté G; Juneau M; Bonan R; Lespérance J; Couturier A; Tardif JC Am J Cardiol; 1999 Aug; 84(3):258-63. PubMed ID: 10496432 [TBL] [Abstract][Full Text] [Related]
18. Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Carlsson J; Miketic S; Mueller KH; Brom J; Ross R; von Essen R; Tebbe U Lancet; 1997 Oct; 350(9086):1225. PubMed ID: 9652570 [No Abstract] [Full Text] [Related]
19. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915 [TBL] [Abstract][Full Text] [Related]
20. Influence of plaque composition on mechanisms of percutaneous transluminal coronary balloon angioplasty assessed by ultrasound imaging. Gil R; Di Mario C; Prati F; von Birgelen C; Ruygrok P; Roelandt JR; Serruys PW Am Heart J; 1996 Mar; 131(3):591-7. PubMed ID: 8604642 [No Abstract] [Full Text] [Related] [Next] [New Search]